Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Business

Musk’s brain implant company filed as a ‘disadvantaged business’

by admin July 20, 2025
July 20, 2025
Musk’s brain implant company filed as a ‘disadvantaged business’

Elon Musk’s health tech company Neuralink labeled itself a “small disadvantaged business” in a federal filing with the U.S. Small Business Administration, shortly before a financing round valued the company at $9 billion.

Neuralink is developing a brain-computer interface (BCI) system, with an initial aim to help people with severe paralysis regain some independence. BCI technology broadly can translate a person’s brain signals into commands that allow them to manipulate external technologies just by thinking.

Neuralink’s filing, dated April 24, would have reached the SBA at a time when Musk was leading the Trump administration’s Department of Government Efficiency. At DOGE, Musk worked to slash the size of federal agencies.

MuskWatch first reported on the details of Neuralink’s April filing.

According to the SBA’s website, a designation of SDB means a company is at least 51% owned and controlled by one or more “disadvantaged” persons who must be “socially disadvantaged and economically disadvantaged.” An SDB designation can also help a business “gain preferential access to federal procurement opportunities,” the SBA website says.

The Department of Justice has previously fined companies for making false claims about their SDB status.

Musk, the world’s wealthiest person, is CEO of Tesla and SpaceX, in addition to his other businesses like artificial intelligence startup xAI and tunneling venture The Boring Company. In 2022, Musk led the $44 billion purchase of Twitter, which he later named X before merging it with xAI.

Jared Birchall, a Neuralink executive, was listed as the contact person on the filing from April. Birchall, who also manages Musk’s money as head of his family office, didn’t immediately respond to a request for comment.

Neuralink, which incorporated in Nevada, closed a $650 million funding round in early June at a $9 billion valuation. ARK Invest, Peter Thiel’s Founders Fund, Sequoia Capital and Thrive Capital were among the investors. Neuralink said the fresh capital would help the company bring its technology to more patients and develop new devices that “deepen the connection between biological and artificial intelligence.”

Under Musk’s leadership at DOGE, the initiative took aim at government agencies that emphasized diversity, equity and inclusion (DEI). In February, for example, DOGE and Musk boasted of nixing hundreds of millions of dollars worth of funding for the Department of Education that would have gone towards DEI-related training grants.

This post appeared first on NBC NEWS

previous post
Three Stocks in Focus: One Old Favorite, One Mag Name, and a Dow Comeback Story
next post
Tech 5: TSMC, ASML Release Latest Results, NVIDIA to Resume Sales to China

Related Posts

Musk says he’s sending Starlink tech to FAA...

March 3, 2025

Nvidia’s CEO did a Q&A with analysts. What...

March 22, 2025

Essence Fest leads a summer of events for...

July 4, 2025

Meta announces end of its DEI programs. Read...

January 12, 2025

Digital health companies got pummeled by Wall Street...

December 26, 2024

Bed Bath & Beyond relaunches with first store...

August 10, 2025

China opens probe into Nvidia, accusing company of...

December 11, 2024

Barry’s Bootcamp announces new investment as others exit...

January 14, 2025

Byron Allen puts broadcast TV stations up for...

June 3, 2025

IRS plans to pay 1 million taxpayers up...

December 25, 2024

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio
  • Republican populism craters as Trump stumbles, Democrats surge
  • Trump admin warned to take front seat as UN chief race shifts left, boosting anti-US contenders
  • GOP unveils plan for ‘Trump Health Freedom Accounts’ to replace Obamacare subsidies with state waivers

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    December 6, 2025
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    December 6, 2025
  • Republican populism craters as Trump stumbles, Democrats surge

    December 6, 2025
  • Trump admin warned to take front seat as UN chief race shifts left, boosting anti-US contenders

    December 6, 2025
  • GOP unveils plan for ‘Trump Health Freedom Accounts’ to replace Obamacare subsidies with state waivers

    December 6, 2025
  • Abortion restrictions create major roadblock for bipartisan Obamacare subsidy deal in Senate

    December 6, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

    September 19, 2025
  • 3

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 4

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 5

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 6

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
  • 7

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
Promotion Image

banner

Categories

  • Business (602)
  • Investing (2,582)
  • Politics (3,117)
  • Stocks (946)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved